RGD Reference Report - Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.

Authors: Jeong, Eun Goo  Kim, Min Sung  Nam, Hyo Kyung  Min, Chang Ki  Lee, Seok  Chung, Yeun Jun  Yoo, Nam Jin  Lee, Sug Hyung 
Citation: Jeong EG, etal., Clin Cancer Res. 2008 Jun 15;14(12):3716-21. doi: 10.1158/1078-0432.CCR-07-4839.
RGD ID: 18936996
Pubmed: PMID:18559588   (View Abstract at PubMed)
DOI: DOI:10.1158/1078-0432.CCR-07-4839   (Journal Full-text)


PURPOSE: The aim of this study was to see whether JAK1, JAK3, and TYK2 genes are altered in human cancers.
EXPERIMENTAL DESIGN: We analyzed 494 tissues from 186 acute adulthood leukemias, 30 multiple myelomas, and 278 common solid cancers, including 90 breast, 47 gastric, 47 colon, 47 lung, and 47 hepatocellular carcinomas by single-strand conformation polymorphism analysis.
RESULTS: Overall, we found six JAK1 mutations (four in acute leukemias, one in a lung carcinoma, and one in a breast carcinoma) and three JAK3 mutations (two in breast carcinomas and one in a gastric carcinoma). Of note, three JAK1 mutations were an identical p.V658F mutation, which is homologous to JAK2 p.V617F mutation. We also found two other JAK1 mutations that occurred at very close sites (p.T782M and p.L783F). We found three of the four leukemias with JAK1 mutations expressed mutated JAK1 at the mRNA level. For JAK3 mutations, one of them was JAK3 p.V715I that is homologous to the JAK1 p.L783F. These recurrent mutations in identical and homologous sites suggest a possibility that alterations of these amino acids might be important for tumor pathogenesis. With respect to the cancer types, T-acute lymphoblastic leukemia (T-ALL) showed the highest incidence of the mutations (3 of 11; 27.3%).
CONCLUSION: Our data indicate that both JAK1 and JAK3 mutations occur in common human cancers and that JAK1 mutation in T-ALL is a frequent event. The data suggest that some of the JAK1 and JAK3 mutations may to be functional and contributes to cancer development, especially to T-ALL development.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
T-cell acute lymphoblastic leukemia  IAGP 18936996DNA:missense mutation: :c.1972G>T (p.V658F) (human)RGD 
T-cell acute lymphoblastic leukemia  ISOJAK1 (Homo sapiens)18936996; 18936996DNA:missense mutation: :c.1972G>T (p.V658F) (human)RGD 

Objects Annotated

Genes (Rattus norvegicus)
Jak1  (Janus kinase 1)

Genes (Mus musculus)
Jak1  (Janus kinase 1)

Genes (Homo sapiens)
JAK1  (Janus kinase 1)


Additional Information